IMN || Oncology

20-year follow-up supports adjuvant radiotherapy for DCIS

Posted on: 13/10/2014 - 21:00

Adjuvant radiotherapy continues to protect against recurrences – ­albeit “modestly” – for a full 20 years after women undergo breast-conserving surgery for DCIS, according to a report published...

Field of Interest: Oncology
Type: News Item

Dose-dense chemo aids high-risk breast cancer patients

Posted on: 08/10/2014 - 20:10

MADRID – A dose-dense, third-generation chemotherapy regimen surpassed a more standard regimen for adjuvant therapy of high-risk breast cancer patients with positive nodes and either triple-negative...

Field of Interest: Oncology
Type: News Item

Rolapitant curbs chemo-induced nausea and vomiting

Posted on: 07/10/2014 - 17:01

MADRID – The investigational neurokinin-1 receptor antagonist rolapitant met all of its endpoints in the prevention of chemotherapy-induced nausea and vomiting in a phase III trial. Among 532...

Field of Interest: Oncology
Type: News Item

New drug boosts survival in metastatic CRC

Posted on: 07/10/2014 - 14:50

MADRID – Treatment with a new nucleoside-analogue drug produced clinically meaningful improvements in survival and performance status in a phase III trial that enrolled 800 patients with metastatic...

Field of Interest: Oncology
Type: News Item

New drug boosts survival in metastatic CRC

Posted on: 07/10/2014 - 14:50

MADRID – Treatment with a new nucleoside-analogue drug produced clinically meaningful improvements in survival and performance status in a phase III trial that enrolled 800 patients with metastatic...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More